Amp Capital Investors LTD Seagen Inc. Transaction History

Amp Capital Investors LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $5.14 Million - $6.88 Million	-36,062 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $157,692 - $187,990	-1,107 Reduced 2.98%	36,062 $6.12 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $1.02 Million - $1.22 Million	-7,573 Reduced 16.93%	37,169 $5.87 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $1.48 Million - $2.05 Million	10,749 Added 31.62%	44,742 $6.21 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $5.6 Million - $7.2 Million	33,993 New	33,993 $6.25 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.